
Amiodarone v Lidocaine: Versus Series
Pharmacy to Dose: The Critical Care Podcast
00:00
The Limits of Randomized Trials
More people in this retrospective analysis were actually given light-acane than amiodorone. In the initial unadjusted analysis light-ACane was better across the board so nick light-acanes better ros 79 or 68 more survival to 24 hours better survival. When you match those patients they took 180 patients and matched them super well so really minimal differences all the covariate covariates controlled at baseline there was no differences among any of the outcomes.
Transcript
Play full episode